TSS
AGIO icon

Two Sigma Securities’s Agios Pharmaceuticals AGIO Stock Holding History

Two Sigma Securities’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,198
Closed -$250K – 1619
2025
Q4 		$250K Buy
+9,198
New +$323K 0.03% 730
2025
Q3 		– Sell
-8,646
Closed -$288K – 1342
2025
Q2 		$288K Buy
+8,646
New +$262K 0.04% 679
2019
Q1 		– Sell
-8,069
Closed -$372K – 1783
2018
Q4 		$372K Buy
+8,069
New +$498K ﹤0.01% 1193
2017
Q3 		– Sell
-4,630
Closed -$238K – 901
2017
Q2 		$238K Buy
+4,630
New +$237K 0.05% 458

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Two Sigma Securities's AGIO Position: Q1 2026 in Review

Two Sigma Securities sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 9,198 shares — an estimated $250K sold.

Two Sigma Securities first reported a position in AGIO in Q2 2017 and held it in 4 quarters. The position peaked at $372K in Q4 2018. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Two Sigma Securities reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 9,198 Agios Pharmaceuticals shares in Q1 2026, an estimated $250K.
  • Two Sigma Securities first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Two Sigma Securities's Agios Pharmaceuticals position peaked at $372K in Q4 2018.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.